查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080347

生物資訊市場：2026-2032年全球市場預測（依產品類型、整合層級、技術、組織規模、部署模式、銷售管道、應用程式和最終用戶分類）

Bioinformatics Market by Product Types, Integration Level, Technology, Organization Size, Deployment Model, Sales Channel, Applications, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物資訊市場將成長至 362.1 億美元，複合年成長率為 13.41%。

主要市場統計數據
基準年 2025 150億美元
預計年份：2026年 169.2億美元
預測年份 2032 362.1億美元
複合年成長率 (%) 13.41%

生物資訊學如今已成為現代生命科學的核心運行層，它將次世代定序、多體學、臨床資訊學、群體遺傳學和藥物發現整合到一個數據驅動的生態系統中。這一發展趨勢源自於生物數據的產生速度已超越傳統的實驗室分析。美國國家人類基因組研究所（NHGRI）報告稱，自人類基因組計畫以來，定序成本已大幅下降，目前每個人類基因組的定序成本已低於1,000美元。此外，諸如英國生物銀行（UK Biobank）、gnomAD、序列讀取檔案庫（SRA）、歐洲核苷酸檔案庫（ENA）以及美國國立衛生研究院（NIH）的「我們所有人」（All of Us）研究計畫等公開資源，清楚地展示了目前可用於研究和轉化醫學的基因組數據的規模。

對於產業領導者而言，生物資訊學市場不再僅僅由序列比對和註釋來定義。競爭優勢越來越依賴可擴展的雲端運算、可互通的數據標準、人工智慧驅動的分析、安全的臨床工作流程以及支援精準醫療、生物標記發現、伴隨診斷、感染疾病監測和循證分析的分析方法，以滿足監管申報要求。

生物資訊學領域的變革性變化

生物資訊學的格局正在從企劃為基礎的分析轉向持續運作的數據基礎設施。定序中心、醫院、製藥公司、受託研究機構和公共衛生機構正在從孤立的流程轉向能夠處理基因組學、轉錄組學、蛋白質組學、代謝組學、診斷代謝體學、真實世界數據和電子健康記錄的整合平台。

人工智慧在生物資訊領域的累積影響

人工智慧正在提升生物資訊學的速度、規模和預測能力。深度學習系統已在蛋白質結構預測、突變優先排序、基於影像的病理診斷、藥物標靶識別以及從生物醫學文獻中提取自然語言等方面展現出顯著價值。 AlphaFold 透過「AlphaFold 蛋白質結構資料庫」發布了超過 2 億個蛋白質的預測結構，這充分體現了人工智慧驅動的計算生物學的潛力。

全球生物資訊學的主要區域趨勢

北美在生物資訊應用方面仍處於領先地位，這得益於美國國立衛生研究院 (NIH) 的資助、主要學術醫療中心、生物製藥公司巨額的研發預算、成熟的雲端基礎設施以及「我們所有人」(All of Us) 等大規模人群計畫。歐洲的特點是擁有強大的公共基因組學計畫、跨境研究網路、基於 GDPR 的數據管治以及「英國基因組學」(Genomics England)、「法國基因組學」(France Genomique) 等國家級計劃，以及德國對醫療資訊學的主導。

關於生物資訊學應用的關鍵群體特定見解

在東協地區，新加坡憑藉生物醫學研究、數位健康基礎設施以及強大的產學合作，引領著區域生物資訊學的發展；而泰國、馬來西亞、印尼、越南和菲律賓則在基因組監測、臨床研究和農業生物技術領域不斷提升自身能力。海灣合作理事會成員國正利用國家基因組計畫、醫院數位化和精準醫療策略，增強本地數據資產，並減少對進口參考人群的依賴。

主要國家生物資訊發展趨勢

美國在商業生物資訊平台、美國國立衛生研究院（NIH）資助的食品藥物管理局研究、美國食品藥物管理局（FDA）監管的精準診斷以及風險創業投資支持的計算生物學領域佔據領先地位。加拿大擁有強大的學術基因組學研究、人工智慧研究和公共衛生專業知識，而墨西哥和巴西則在臨床基因組學、感染疾病研究和農業生物資訊學領域迅速發展。英國透過英國基因組學中心（Genomics England）、英國生物銀行（UK Biobank）以及與英國國家醫療服務體系（NHS）合作的基因組整合項目，持續維持著主導。

為行業領導者提供的實用建議

產業領導者應優先考慮高度互通性的雲端生物資訊架構，以支援多組體學資料的整合、可重複的流程以及調查團隊和臨床團隊之間的安全協作。投資於 FAIR 資料原則、標準化元資料、工作流程自動化和 API主導的平台設計，可以緩解分析瓶頸並改善下游證據的產生。

調查方法

本執行摘要基於一項二次調查，該調查綜合運用了公開的科學、監管和機構資源，包括同行評審的生物資訊學文獻、國家基因組學計劃的資訊披露、公共資料庫中的文件、衛生機構出版刊物、監管指南以及行業檢驗的資訊來源，檢驗定序成本的降低、公開可用隊列的規模、人工智慧模型部署里程碑、監管趨勢以及已記錄的區域基因組舉措。

結論

生物資訊學已成為精準醫療、藥物研發、診斷、公共衛生和生物技術領域企業競爭的關鍵能力。隨著定序成本的下降、雲端運算能力的提升、群體基因組學的發展、多體學整合以及人工智慧分析的融合，生物數據正在轉變為一種策略資產。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 生物資訊市場：依產品類型分類

  • 平台
    • 陣列對齊平台
    • 序列分析平台
    • 序列操作平台
    • 結構和功能分析平台
  • 服務
    • 數據分析
    • 資料庫管理
    • 定序
    • 諮詢和顧問服務
  • 軟體
    • 轉錄混合軟體
    • 知識管理工具
    • 分子建模和模擬工具

第8章：生物資訊市場：依整合程度分類

  • 獨立解決方案
  • 整合套件

第9章：生物資訊市場：依技術分類

  • 次世代定序（NGS）分析
  • 質譜分析
  • CRISPR和基因編輯分析
  • 人工智慧和機器學習

第10章：生物資訊市場：依組織規模分類

  • 小型企業
  • 大公司

第11章：生物資訊學市場：依部署模式分類

  • 現場
  • 基於雲端的
    • 公共雲端
    • 私有雲端

第12章：生物資訊市場：依銷售管道分類

  • 直銷
  • 系統整合商
  • OEM夥伴關係

第13章：生物資訊市場：依應用領域分類

  • 農業生物技術
    • 基因改造生物開發
    • 植物育種工具
  • 臨床診斷
  • 藥物發現與開發
    • 藥物篩檢
    • 目標識別
  • 基因組學
    • 比較基因組學
    • 功能基因體學
  • 蛋白質體學和代謝體學

第14章 生物資訊市場：依最終用戶分類

  • 學術研究機構
  • 農業與環境
  • 醫療服務提供方
  • 製藥和生物技術公司

第15章 生物資訊市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章 生物資訊市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 生物資訊市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • Dassault Systemes SE
  • DNASTAR, Inc.
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd
  • Genevia Technologies Oy
  • Genomics Ltd.
  • HaploX
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Labcorp Genetics Inc.
  • Labvantage-Biomax GmbH
  • Novo Nordisk A/S
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc.
  • Qiagen NV
  • RIKEN GENESIS CO.,LTD.
  • SOPHiA GENETICS SA
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
  • Waters Corporation
Product Code: MRR-434CCDA04CC1

The Bioinformatics Market is projected to grow by USD 36.21 billion at a CAGR of 13.41% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.00 billion
Estimated Year [2026] USD 16.92 billion
Forecast Year [2032] USD 36.21 billion
CAGR (%) 13.41%

Bioinformatics is now a core operating layer for modern life sciences, connecting next-generation sequencing, multi-omics, clinical informatics, population genetics, and drug discovery into a single data-driven ecosystem. The field has expanded because biological data generation has outpaced traditional laboratory interpretation: the National Human Genome Research Institute has documented the steep fall in sequencing costs from the Human Genome Project era to sub-USD 1,000 human genomes, while public resources such as UK Biobank, gnomAD, the Sequence Read Archive, the European Nucleotide Archive, and the NIH All of Us Research Program demonstrate the scale of genomic data now available for research and translational medicine.

For industry leaders, the bioinformatics market is no longer defined only by sequence alignment or annotation. Competitive advantage increasingly depends on scalable cloud computing, interoperable data standards, AI-assisted interpretation, secure clinical workflows, and evidence-ready analytics that can support precision medicine, biomarker discovery, companion diagnostics, infectious disease surveillance, and regulatory-grade submissions.

Transformative Shifts in the Bioinformatics Landscape

The bioinformatics landscape is shifting from project-based analysis to continuously operating data infrastructure. Sequencing centers, hospitals, pharmaceutical companies, contract research organizations, and public health agencies are moving from isolated pipelines toward integrated platforms capable of handling genomics, transcriptomics, proteomics, metabolomics, imaging, real-world data, and electronic health records.

A second major shift is the move from research-only bioinformatics to clinically actionable bioinformatics. Cancer genomics, rare disease diagnosis, infectious disease surveillance, pharmacogenomics, and reproductive health testing all require faster variant interpretation, stronger quality controls, and transparent audit trails. At the same time, open science initiatives and population-scale cohorts are improving reference datasets, while privacy regulation, data localization rules, and data sovereignty requirements are reshaping where and how biological data can be processed.

Cumulative Impact of Artificial Intelligence in Bioinformatics

Artificial intelligence is expanding the speed, scale, and predictive power of bioinformatics. Deep learning systems have already demonstrated measurable value in protein structure prediction, variant prioritization, image-based pathology, drug-target identification, and natural language extraction from biomedical literature. AlphaFold's public release of predicted protein structures for more than 200 million proteins through the AlphaFold Protein Structure Database marked a significant proof point for AI-enabled computational biology.

The cumulative impact of AI is strongest when models are paired with high-quality curated data, reproducible workflows, and domain validation. In genomics and multi-omics, AI can reduce manual review burden and reveal non-linear biological patterns; however, clinical deployment requires explainability, bias testing across ancestries, cybersecurity safeguards, human oversight, and compliance with regulatory expectations for software, diagnostics, and patient data protection.

Key Regional Insights Across Global Bioinformatics

North America remains a leading region for bioinformatics adoption, supported by NIH funding, major academic medical centers, large biopharma R&D budgets, mature cloud infrastructure, and population-scale programs such as All of Us. Europe is characterized by strong public genomics programs, cross-border research networks, GDPR-driven data governance, and national initiatives such as Genomics England, France Genomique, and Germany's medical informatics investments.

Asia-Pacific is accelerating rapidly through large sequencing capacity, government-backed precision medicine programs, and expanding biotechnology hubs in China, India, Japan, South Korea, Singapore, and Australia. Latin America is building momentum through infectious disease genomics, agricultural biotechnology, and cancer research, with Brazil and Mexico playing important roles in regional capacity building. The Middle East is investing in national genome strategies and digital health modernization, particularly in Gulf countries, while Africa's bioinformatics growth is linked to pathogen surveillance, human genetic diversity research, and capacity-building networks such as H3Africa's legacy in genomic research infrastructure.

Key Group Insights for Bioinformatics Adoption

Within ASEAN, Singapore anchors regional bioinformatics through biomedical research, digital health infrastructure, and strong university-industry collaboration, while Thailand, Malaysia, Indonesia, Vietnam, and the Philippines are expanding genomic surveillance, clinical research, and agricultural biotechnology capacity. The GCC is using national genome projects, hospital digitization, and precision medicine strategies to strengthen local data assets and reduce reliance on imported reference populations.

The European Union benefits from coordinated research funding, data protection frameworks, and initiatives that support secure health data exchange. BRICS economies bring scale through large patient populations, cost-competitive sequencing, public health genomics, and growing AI talent, although infrastructure maturity varies. The G7 continues to lead in high-value pharmaceutical R&D, advanced diagnostics, biomedical data standards, and cloud-enabled bioinformatics platforms, while NATO members increasingly recognize bioinformatics as relevant to biosecurity, biodefense, and resilient public health surveillance.

Key Country Insights in Bioinformatics

The United States leads in commercial bioinformatics platforms, NIH-funded genomics, FDA-regulated precision diagnostics, and venture-backed computational biology. Canada combines strong academic genomics, AI research, and population health expertise, while Mexico and Brazil are expanding clinical genomics, infectious disease research, and agricultural bioinformatics. The United Kingdom remains influential through Genomics England, UK Biobank, and NHS-linked genomics integration.

Germany, France, Italy, and Spain are advancing medical informatics, oncology genomics, rare disease research, and biobank-enabled studies, while Russia maintains capabilities in computational biology and infectious disease science despite geopolitical constraints. China is a global sequencing powerhouse with large-scale genomics capacity and AI investment; India is scaling bioinformatics through genomics programs, digital public infrastructure, and a large technology workforce. Japan, South Korea, and Australia contribute advanced clinical research, cancer genomics, proteomics, population health analytics, and translational bioinformatics capabilities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable, cloud-ready bioinformatics architectures that can support multi-omics data integration, reproducible pipelines, and secure collaboration across research and clinical teams. Investments in FAIR data principles, standardized metadata, workflow automation, and API-driven platform design can reduce analytical bottlenecks and improve downstream evidence generation.

Organizations should also establish governance for AI-enabled bioinformatics, including model validation, bias monitoring, data provenance, cybersecurity, human-in-the-loop review, and regulatory readiness. Strategic partnerships with academic centers, sequencing providers, cloud infrastructure partners, clinical laboratories, and population health programs can accelerate innovation while improving access to diverse datasets and clinically relevant expertise.

Research Methodology

This executive summary is based on triangulated secondary research from publicly available scientific, regulatory, and institutional sources, including peer-reviewed bioinformatics literature, national genomics program disclosures, public database documentation, health agency publications, regulatory guidance, and industry-relevant technology reports. Emphasis is placed on verifiable indicators such as sequencing cost declines, public cohort scale, AI model deployment milestones, regulatory developments, and documented regional genomics initiatives.

The methodology assesses market direction through qualitative synthesis rather than speculative forecasting. Insights were structured around demand drivers, technology adoption, regional infrastructure, policy environment, clinical translation, and competitive implications for organizations operating in genomics data analytics, computational biology, precision medicine, multi-omics informatics, and AI-enabled life sciences.

Conclusion

Bioinformatics has become an essential capability for organizations competing in precision medicine, drug discovery, diagnostics, public health, and biotechnology. The convergence of lower sequencing costs, cloud-scale computation, population genomics, multi-omics integration, and AI-enabled analytics is transforming biological data into a strategic asset.

The next phase of market leadership will depend on trusted data infrastructure, validated AI workflows, regulatory-grade evidence, and the ability to translate multi-omics insights into clinical and commercial decisions. Organizations that combine scientific rigor with scalable digital execution will be best positioned to capture the long-term value of bioinformatics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Bioinformatics Market, by Product Types

  • 7.1. Platforms
    • 7.1.1. Sequence Alignment Platforms
    • 7.1.2. Sequence Analysis Platforms
    • 7.1.3. Sequence Manipulation Platforms
    • 7.1.4. Structural & Functional Analysis Platforms
  • 7.2. Services
    • 7.2.1. Data Analysis
    • 7.2.2. Database Management
    • 7.2.3. Sequencing
    • 7.2.4. Consulting & Advisory
  • 7.3. Software
    • 7.3.1. Transcriptomics Software
    • 7.3.2. Knowledge Management Tools
    • 7.3.3. Molecular Modeling & Simulation Tools

8. Bioinformatics Market, by Integration Level

  • 8.1. Standalone Solutions
  • 8.2. Integrated Suites

9. Bioinformatics Market, by Technology

  • 9.1. Next-Generation Sequencing (NGS) Analytics
  • 9.2. Mass Spectrometry Analytics
  • 9.3. CRISPR & Gene Editing Analysis
  • 9.4. Artificial Intelligence & Machine Learning

10. Bioinformatics Market, by Organization Size

  • 10.1. Small & Mid-Sized Enterprises
  • 10.2. Large Enterprises

11. Bioinformatics Market, by Deployment Model

  • 11.1. On-Premises
  • 11.2. Cloud-Based
    • 11.2.1. Public Cloud
    • 11.2.2. Private Cloud

12. Bioinformatics Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. System Integrators
  • 12.3. OEM Partnerships

13. Bioinformatics Market, by Applications

  • 13.1. Agricultural Biotechnology
    • 13.1.1. GMOs Development
    • 13.1.2. Plant Breeding Tools
  • 13.2. Clinical Diagnostics
  • 13.3. Drug Discovery & Development
    • 13.3.1. Drug Screening
    • 13.3.2. Target Identification
  • 13.4. Genomics
    • 13.4.1. Comparative Genomics
    • 13.4.2. Functional Genomics
  • 13.5. Proteomics & Metabolomics

14. Bioinformatics Market, by End-User

  • 14.1. Academic & Research Institutes
  • 14.2. Agricultural & Environmental Sectors
  • 14.3. Healthcare Providers
  • 14.4. Pharmaceutical & Biotechnology Companies

15. Bioinformatics Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. North America
  • 15.3. Latin America
  • 15.4. Europe
  • 15.5. Middle East
  • 15.6. Africa

16. Bioinformatics Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Bioinformatics Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. 10x Genomics, Inc.
  • 19.2. Agilent Technologies, Inc.
  • 19.3. BGI Group
  • 19.4. Bio-Rad Laboratories, Inc.
  • 19.5. BioDiscovery Group
  • 19.6. biomodal Limited
  • 19.7. Dassault Systemes S.E.
  • 19.8. DNASTAR, Inc.
  • 19.9. Eurofins Genomics LLC
  • 19.10. F. Hoffmann-La Roche Ltd
  • 19.11. Genevia Technologies Oy
  • 19.12. Genomics Ltd.
  • 19.13. HaploX
  • 19.14. Illumina, Inc.
  • 19.15. Integrated DNA Technologies, Inc.
  • 19.16. Labcorp Genetics Inc.
  • 19.17. Labvantage - Biomax GmbH
  • 19.18. Novo Nordisk A/S
  • 19.19. Oxford Nanopore Technologies plc.
  • 19.20. Pacific Biosciences of California, Inc.
  • 19.21. Partek Incorporated
  • 19.22. PerkinElmer, Inc.
  • 19.23. Qiagen N.V.
  • 19.24. RIKEN GENESIS CO.,LTD.
  • 19.25. SOPHiA GENETICS SA
  • 19.26. Telesis Bio Inc.
  • 19.27. Thermo Fisher Scientific Inc.
  • 19.28. Veracyte, Inc.
  • 19.29. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOINFORMATICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIOINFORMATICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIOINFORMATICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIOINFORMATICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOINFORMATICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIOINFORMATICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIOINFORMATICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL BIOINFORMATICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SEQUENCE ALIGNMENT PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEQUENCE ALIGNMENT PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SEQUENCE ALIGNMENT PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SEQUENCE ANALYSIS PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SEQUENCE ANALYSIS PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SEQUENCE ANALYSIS PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SEQUENCE MANIPULATION PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SEQUENCE MANIPULATION PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SEQUENCE MANIPULATION PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DATA ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DATA ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DATABASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DATABASE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DATABASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONSULTING & ADVISORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONSULTING & ADVISORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONSULTING & ADVISORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TRANSCRIPTOMICS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TRANSCRIPTOMICS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TRANSCRIPTOMICS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL KNOWLEDGE MANAGEMENT TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL KNOWLEDGE MANAGEMENT TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL KNOWLEDGE MANAGEMENT TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MOLECULAR MODELING & SIMULATION TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MOLECULAR MODELING & SIMULATION TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MOLECULAR MODELING & SIMULATION TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STANDALONE SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STANDALONE SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STANDALONE SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTEGRATED SUITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTEGRATED SUITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTEGRATED SUITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEXT-GENERATION SEQUENCING (NGS) ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEXT-GENERATION SEQUENCING (NGS) ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEXT-GENERATION SEQUENCING (NGS) ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MASS SPECTROMETRY ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MASS SPECTROMETRY ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MASS SPECTROMETRY ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CRISPR & GENE EDITING ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CRISPR & GENE EDITING ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CRISPR & GENE EDITING ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE & MACHINE LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE & MACHINE LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE & MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SMALL & MID-SIZED ENTERPRISES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SMALL & MID-SIZED ENTERPRISES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SMALL & MID-SIZED ENTERPRISES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ON-PREMISES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ON-PREMISES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ON-PREMISES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PRIVATE CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PRIVATE CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PRIVATE CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SYSTEM INTEGRATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SYSTEM INTEGRATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SYSTEM INTEGRATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL OEM PARTNERSHIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL OEM PARTNERSHIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL OEM PARTNERSHIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GMOS DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GMOS DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GMOS DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PLANT BREEDING TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PLANT BREEDING TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PLANT BREEDING TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DRUG SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL COMPARATIVE GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPARATIVE GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL COMPARATIVE GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PROTEOMICS & METABOLOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PROTEOMICS & METABOLOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PROTEOMICS & METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL AGRICULTURAL & ENVIRONMENTAL SECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL AGRICULTURAL & ENVIRONMENTAL SECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL AGRICULTURAL & ENVIRONMENTAL SECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIOINFORMATICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 256. GCC BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 258. GCC BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 259. GCC BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 260. GCC BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 261. GCC BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 262. GCC BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 265. GCC BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 266. GCC BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. GCC BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. GCC BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 270. GCC BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 271. GCC BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 304. G7 BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. G7 BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 306. G7 BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 307. G7 BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 308. G7 BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 309. G7 BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 310. G7 BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. G7 BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. G7 BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 313. G7 BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 314. G7 BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. G7 BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 316. G7 BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. G7 BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 318. G7 BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 319. G7 BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 320. NATO BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 321. NATO BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 322. NATO BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 323. NATO BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 324. NATO BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 325. NATO BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 326. NATO BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 327. NATO BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. NATO BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 329. NATO BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 330. NATO BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 331. NATO BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 332. NATO BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 333. NATO BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 334. NATO BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 335. NATO BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 336. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED STATES BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED STATES BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED STATES BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 353. CANADA BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. CANADA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2032 (USD MILLION)
  • TABLE 355. CANADA BIOINFORMATICS MARKET SIZE, BY PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 356. CANADA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 357. CANADA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 358. CANADA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 359. CANADA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 360. CANADA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
  • TABLE 361. CANADA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 362. CANADA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 363. CANADA BIOINFORMATICS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 364. CANADA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 365. CANADA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 366. CANADA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 367. CANADA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 368. CANADA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 369. MEXICO BIOINFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)

T